title: Clinical inquiries. What GI stress ulcer prophylaxis should we provide hospitalized patients?
authors.affiliation: Miami Valley Hospital Family Practice Residency, Dayton, OH, USA.
authors.forename: Alisha
authors.initials: A
authors.lastname: Saultz
authors.forename: Dolores Zegar
authors.initials: DZ
authors.lastname: Judkins
authors.forename: John W
authors.initials: JW
authors.lastname: Saultz
authors.forename: Julia
authors.initials: J
authors.lastname: Fashner
mesh_terms: D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D003422:Critical Care; D004381:Duodenal Ulcer / Q000209:etiology / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D020380:Needs Assessment; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D013276:Stomach Ulcer / Q000209:etiology / Q000517:prevention & control*; D013312:Stress, Physiological / Q000150:complications*
chemical_list: D000897:Anti-Ulcer Agents